The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...

This drug may reduce the risk of addiction to pain medications by decreasing reliance on opioids to reduce pain.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

A James Island pharmacist is looking to the future of pain management thanks to the Food and Drug Administration approving a ...

In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated statistically significant reductions in acute surgical pain over 48 hours ...

This is the first new type of pain medication to be approved in more than 20 years It is anticipated that payers will see an up-tick in the number of requests for this new drug. Journavx will ...

And Vertex has recently succeeded in doing just that after receiving approval for its NaV1.8 inhibitor. FDA approves Vertex Pharmaceuticals’ non-opioid pain medication Journavx On January 30 2025, in ...